Journal Article DKFZ-2021-02147

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2021
Springer Heidelberg

Acta neuropathologica 142(6), 1065-1069 () [10.1007/s00401-021-02369-1]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Classification:

Note: #EA:B300#LA:B300# / 2021 Dec;142(6):1065-1069

Contributing Institute(s):
  1. KKE Neuropathologie (B300)
  2. DKTK HD zentral (HD01)
  3. B062 Pädiatrische Neuroonkologie (B062)
  4. KKE Pädiatrische Onkologie (B310)
  5. Pediatric Glioma (B360)
  6. DKTK ED ES zentral (ED01)
  7. DKTK BE zentral (BE01)
  8. KKE Neuroonkologie (B320)
Research Program(s):
  1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2021
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2021-10-11, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)